Bath & Body Works Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call — Neutral
BBWI Benzinga — February 26, 2025Bath & Body Works, Inc. BBWI will release its fourth-quarter financial results before the opening bell on Thursday, Feb. 27.

QTUM: Our Favorite Way To Invest In Quantum Computing — Positive
QTUM Seeking Alpha — February 26, 2025The Defiance Quantum ETF offers diversified exposure to quantum computing and related tech sectors, balancing speculative and established companies. QTUM's historical performance has outpaced broader tech and S&P 500 indices, demonstrating its strong blend of growth and speculative potential. Despite high valuations in the industry, QTUM's diversified portfolio positions investors to benefit from future quantum computing breakthroughs, while maintaining appreciation prospects in the meantime. Thus, our 'Buy' rating.

Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript — Neutral
HCAT Seeking Alpha — February 26, 2025Health Catalyst, Inc. (NASDAQ:HCAT ) Q4 2024 Earnings Call Transcript February 26, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Sameer Patel - Evercore ISI John Pinney - Canaccord Genuity Daniel Grosslight - Citi David Larsen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Operator Welcome to the Health Catalyst's Fourth Quarter and Full Year 2024 Earnings …

Vir Biotechnology, Inc. (VIR) Q4 2024 Earnings Call Transcript — Neutral
VIR Seeking Alpha — February 26, 2025Vir Biotechnology, Inc. (NASDAQ:VIR ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Richard Lepke - Senior Director, Investor Relations Marianne De Backer - Chief Executive Officer Mark Eisner - Executive Vice President & Chief Medical Officer Jason O'Byrne - Executive Vice President & Chief Financial Officer Mika Derynck - Executive Vice President of Therapeutic Head Oncology Conference Call Participants Hang Hu - Barclays Paul Choi - Goldman Sachs Phil Nadeau - TD Cowen Alec Stranahan - Bank of America Joseph Stringer - Needham Patrick Trucchio - H.C. Wainwright & Co. Operator Hello.

Spok Holdings, Inc. (SPOK) Q4 2024 Earnings Call Transcript — Neutral
SPOK Seeking Alpha — February 26, 2025Spok Holdings, Inc. (NASDAQ:SPOK ) Q4 2024 Earnings Conference Call February 26, 2025 5:00 PM ET Company Participants Al Galgano - Investor Relations Vincent Kelly - President and CEO Michael Wallace - President and Chief Operating Officer Calvin Rice - Chief Financial Officer Conference Call Participants Kyle Bauser - B. Riley Securities John Dixon - Artemis Investment Group Operator Greetings, and welcome to Spok Holdings, Inc. Fourth Quarter 2024 Earnings Results Conference Call.

Taiwan Fund: Maximally Levered To Global Tech Trends — Positive
TWN Seeking Alpha — February 26, 2025The Taiwan Fund has doubled down on ‘picks and shovels' tech. There's more risk, but also more reward if things go right. Fundamentally, the fund checks a lot of boxes here.

ADTRAN Holdings, Inc. reports preliminary fourth quarter and full-year 2024 financial results — Neutral
ADTN Business Wire — February 26, 2025HUNTSVILLE, Ala.--(BUSINESS WIRE)--ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) (“ADTRAN Holdings” or the “Company”) today announced its preliminary unaudited financial results for the fourth quarter and full-year ended December 31, 2024. Revenue: $242.9 million, up 7% sequentially and above the mid-point of outlook. Gross margin: GAAP gross margin: 37.6%; non-GAAP gross margin: 42.0%. Operating margin: improved sequentially on a GAAP and non-GAAP basis, above the mid-point of outlook. GAA.

Why Gilead Sciences Remains A Buy After A 40% Rally — Positive
GILD Seeking Alpha — February 26, 2025Two weeks ago, Gilead Sciences released financial results for the fourth quarter of 2024, which exceeded even my most optimistic expectations. The strong performance of its HIV franchise was driven by rising demand for Biktarvy, Descovy, and Sunlenca. So, sales of Biktarvy, the flagship of Gilead's HIV franchise, amounted to $3.77 billion, an increase of 21.4% year-on-year.

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript — Neutral
MDXG Seeking Alpha — February 26, 2025MiMedx Group, Inc. (NASDAQ:MDXG ) Q4 2024 Earnings Conference Call February 26, 2024 4:30 AM ET Company Participants Matt Notarianni - Head, Investor Relations Joseph Capper - Chief Executive Officer Doug Rice - Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig-Hallum Group Ross Osborn - Cantor Fitzgerald Bradley Bowers - Mizuho Securities Brooks O'Neil - Lake Street Capital Markets Carl Byrnes - Northland Capital Markets Operator Good afternoon, and thank you for standing by. Welcome to the MiMedx Fourth Quarter and Full Year 2024 Operating Financial Results Conference Call.

The Vanguard Core-Plus Bond ETF is an actively managed fund focusing on investment-grade U.S. bonds, with selective exposure to below-investment-grade and emerging market debt. VPLS has outperformed the iShares Core U.S. Aggregate Bond ETF by over 150 bps since inception, thanks to active management and strategic bond selection. The ETF's intermediate duration of 5.8 years and 4.9% 30-day SEC yield make it attractive in today's high-rate environment.

Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc (GSK) — Neutral
GSK Accesswire — February 26, 2025NEW YORK, NY / ACCESS Newswire / February 26, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=132592&wire=1 or contact Joseph E. Levi, Esq.

Zeta Global Holdings Corp. (ZETA) Q4 2024 Earnings Call Transcript — Neutral
ZETA Seeking Alpha — February 26, 2025Zeta Global Holdings Corp. (NYSE:ZETA ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Matt Pfau - Senior Vice President of Investor Relations David Steinberg - Co-Founder, Chairman and CEO Chris Greiner - CFO Conference Call Participants DJ Hynes - Canaccord Genuity Jason Kreyer - Craig-Hallum Ryan MacDonald - Needham Terry Tillman - Truist Securities Arjun Bhatia - William Blair Katie Keyser - Morgan Stanley Jack Nichols - KeyBanc Koji Ikeda - Bank of America Brian Schwartz - Oppenheimer Zach Cummins - B. Riley Securities Richard Baldry - ROTH Capital Partners Eamon Coughlin - Barclays …

First Solar appears undervalued with a forward P/E of 8.1x, but the 45X tax credit significantly distorts its profitability and valuation. Excluding the 45X credit, FSLR's valuation is less attractive, with an EV/EBIT multiple of 34x and high capital needs. Political risks and potential repeal of the 45X credit pose significant challenges, but tariffs and domestic manufacturing support could stabilize FSLR.

Meta apologizes after Instagram users flag flood of graphic and violent content — Negative
META CNBC — February 26, 2025Meta said it is fixing an error that caused some users to see content in their Instagram Reels feed "that should not have been recommended," a Meta spokesperson said. It comes after users took to social media to complain about a sudden wave of recommended content that included violent and sexual imagery.

Shareholders that lost money on Crocs, Inc.(CROX) should contact Levi & Korsinsky about pending Class Action - CROX — Neutral
CROX Accesswire — February 26, 2025NEW YORK, NY / ACCESS Newswire / February 26, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=132591&wire=1 or contact Joseph E. Levi, Esq.

Miller Industries: Assessing Whether Q4 Earnings Will Get Investors Interested Again — Negative
MLR Seeking Alpha — February 26, 2025Despite Miller Industries' strong trailing growth, high inventory levels and tough comparables signal potential challenges ahead. MLR stock's MACD indicator suggests a potential sell signal unless Q4 results impress investors. Miller's high retention ratio limits its scope for sustained above-average growth, raising concerns about long-term value creation.

Core Scientific, Inc. (CORZ) Q4 2024 Earnings Call Transcript — Neutral
CORZ Seeking Alpha — February 26, 2025Core Scientific, Inc. (NASDAQ:CORZ ) Q4 2024 Earnings Call Transcript February 26, 2025 4:30 PM ET Company Participants Jon Charbonneau - Vice President, Investor Relations Adam Sullivan - CEO, President & Director Denise Sterling - Chief Financial Officer Conference Call Participants Darren Aftahi - Roth MKM Jon Petersen - Jefferies Joe Flynn - Compass Point Research Brett Knoblauch - Cantor Fitzgerald Greg Lewis - BTIG George Sutton - Craig Hallum Stephen Glagola - JonesTrading John Todaro - Needham & Company Kevin Dede - H.C. Wainwright Nick Giles - B Riley Joseph Vafi - Canaccord Genuity Bill Papanastasiou - Stifel Rosemarie …

The Honest Company, Inc. (HNST) Q4 2024 Earnings Call Transcript — Neutral
HNST Seeking Alpha — February 26, 2025The Honest Company, Inc. (NASDAQ:HNST ) Q4 2024 Earnings Conference Call February 26, 2025 4:45 PM ET Company Participants Elizabeth Bouquard - Senior Director, Investor Relations Carla Vernon - Chief Executive Officer Dave Loretta - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Andrea Lisher - JPMorgan Anna Glaessgen - B. Riley Securities Ryan Meyers - Lake Street Capital Markets Owen Richard - Northland Capital Markets Operator Ladies and gentlemen, thank you for standing by.

Kratos Defense & Security Solutions, Inc. (KTOS) Q4 2024 Earnings Conference Call Transcript — Neutral
KTOS Seeking Alpha — February 26, 2025Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS ) Q4 2024 Earnings Conference Call February 26, 2025 5:00 PM ET Company Participants Marie Mendoza - SVP & General Counsel Eric DeMarco - President & CEO Deanna Lund - EVP & CFO Conference Call Participants Josh Sullivan - Benchmark Company Seth Seifman - JPMorgan Mike Crawford - B. Riley Securities Jan Engelbrecht - Baird Ken Herbert - RBC Capital Markets Michael Ciarmoli - Truist Securities Noah Poponak - Goldman Sachs Trevor Walsh - Citizens JMP Joshua Zoepfel - Noble Capital Markets Andre Madrid - BTIG Pete Skibitski - Alembic Global Sheila Kahyaoglu …

Digimarc Corporation (DMRC) Q4 2024 Earnings Call Transcript — Neutral
DMRC Seeking Alpha — February 26, 2025Digimarc Corporation (NASDAQ:DMRC ) Q4 2024 Earnings Conference Call February 26, 2025 5:00 PM ET Company Participants George Karamanos - Chief Legal Officer Riley McCormack - Chief Executive Officer Charles Beck - Chief Financial Officer Conference Call Participants Joshua Reilly - Needham & Company Jeff Van Rhee - Craig-Hallum Capital Group Jeffrey Bernstein - Silverberg Bernstein Capital Operator Ladies and gentlemen, greetings, and welcome to the Digimarc Corporation Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
